120 related articles for article (PubMed ID: 2381507)
1. PET and P300 relationships in early Alzheimer's disease.
Marsh JT; Schubarth G; Brown WS; Riege W; Strandburg R; Dorsey D; Maltese A; Kuhl D
Neurobiol Aging; 1990; 11(4):471-6. PubMed ID: 2381507
[TBL] [Abstract][Full Text] [Related]
2. P300 in Alzheimer's disease: relationships to dementia severity and glucose metabolism.
Szelies B; Mielke R; Grond M; Heiss WD
J Neurol Sci; 1995 May; 130(1):77-81. PubMed ID: 7650534
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal P300 latency changes in Alzheimer's disease.
Ball SS; Marsh JT; Schubarth G; Brown WS; Strandburg R
J Gerontol; 1989 Nov; 44(6):M195-200. PubMed ID: 2809106
[TBL] [Abstract][Full Text] [Related]
4. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
6. Associations of event-related brain potentials and Alzheimer's disease severity: A longitudinal study.
Fruehwirt W; Dorffner G; Roberts S; Gerstgrasser M; Grossegger D; Schmidt R; Dal-Bianco P; Ransmayr G; Garn H; Waser M; Benke T
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():31-38. PubMed ID: 30582941
[TBL] [Abstract][Full Text] [Related]
7. The clinical utility of the auditory P300 latency subcomponent event-related potential in preclinical diagnosis of patients with mild cognitive impairment and Alzheimer's disease.
Howe AS; Bani-Fatemi A; De Luca V
Brain Cogn; 2014 Apr; 86():64-74. PubMed ID: 24565814
[TBL] [Abstract][Full Text] [Related]
8. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.
Ibáñez V; Pietrini P; Alexander GE; Furey ML; Teichberg D; Rajapakse JC; Rapoport SI; Schapiro MB; Horwitz B
Neurology; 1998 Jun; 50(6):1585-93. PubMed ID: 9633698
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
[TBL] [Abstract][Full Text] [Related]
10. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
[TBL] [Abstract][Full Text] [Related]
11. Event-related evoked potential P300 in frontotemporal dementia.
Jiménez-Escrig A; Fernandez-Lorente J; Herrero A; Baron M; Lousa M; de Blas G; Gobernado J
Dement Geriatr Cogn Disord; 2002; 13(1):27-32. PubMed ID: 11731712
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
Foster NL; Chase TN; Fedio P; Patronas NJ; Brooks RA; Di Chiro G
Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
[TBL] [Abstract][Full Text] [Related]
13. Regional cerebral glucose transport and utilization in Alzheimer's disease.
Friedland RP; Jagust WJ; Huesman RH; Koss E; Knittel B; Mathis CA; Ober BA; Mazoyer BM; Budinger TF
Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318
[TBL] [Abstract][Full Text] [Related]
14. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study.
Pietrini P; Furey ML; Alexander GE; Mentis MJ; Dani A; Guazzelli M; Rapoport SI; Schapiro MB
Am J Psychiatry; 1999 Mar; 156(3):470-3. PubMed ID: 10080567
[TBL] [Abstract][Full Text] [Related]
15. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
16. P300 latency and amplitude in the diagnosis of dementia.
Ortiz T; Martin Loeches M; Miguel F; Abdad EV; Puente AE
J Clin Psychol; 1994 May; 50(3):381-8. PubMed ID: 8071443
[TBL] [Abstract][Full Text] [Related]
17. Auditory and visual event-related potentials and flash visual evoked potentials in Alzheimer's disease: correlations with Mini-Mental State Examination and Raven's Coloured Progressive Matrices.
Tanaka F; Kachi T; Yamada T; Sobue G
J Neurol Sci; 1998; 156(1):83-8. PubMed ID: 9559992
[TBL] [Abstract][Full Text] [Related]
18. Combined study of cerebral glucose metabolism and [11C]methionine accumulation in probable Alzheimer's disease using positron emission tomography.
Salmon E; Gregoire MC; Delfiore G; Lemaire C; Degueldre C; Franck G; Comar D
J Cereb Blood Flow Metab; 1996 May; 16(3):399-408. PubMed ID: 8621744
[TBL] [Abstract][Full Text] [Related]
19. Cognitive Event-Related Potential, an Early Diagnosis Biomarker in Frail Elderly Subjects: The ERP-MAPT-PLUS Ancillary Study.
Bennys K; Gabelle A; Berr C; De Verbizier D; Andrieu S; Vellas B; Touchon J;
J Alzheimers Dis; 2017; 58(1):87-97. PubMed ID: 28372327
[TBL] [Abstract][Full Text] [Related]
20. Cognitive MMN and P300 in mild cognitive impairment and Alzheimer's disease: A high density EEG-3D vector field tomography approach.
Papadaniil CD; Kosmidou VE; Tsolaki A; Tsolaki M; Kompatsiaris IY; Hadjileontiadis LJ
Brain Res; 2016 Oct; 1648(Pt A):425-433. PubMed ID: 27485659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
